Kuzucuoglu Mustafa, Gokyer Ali, Kula Osman, Yekdes Ali Cem, Sunal Baran Serdar, Karamustafaoglu Yekta Altemur, Yoruk Yener, Cicin Irfan
Department of Thoracic Surgery, Medical Faculty, Balikesir University, Balikesir, Turkey.
Department of Medical Oncology, Medical Faculty, Trakya University, Edirne, Turkey.
J Coll Physicians Surg Pak. 2020 Feb;30(2):172-176. doi: 10.29271/jcpsp.2020.02.172.
To determine whether there is a relationship between the size and location of the mass and lymph node metastasis in non-small cell lung cancer.
Observational study.
Department of Medical Oncology of Trakya University, from November 2013 to November 2018.
Records of 112 patients, who were followed up for non-small cell lung cancer, were retrospectively reviewed. Patients with distant organ metastasis (M1) and distant lymph node metastasis (N3), a previous history of malignancy, synchronous or metachronous tumors, and those for whom required data could not be obtained were excluded. Lymph nodes were evaluated according to pathology reports in patients undergoing invasive procedures. In patients without invasive procedures, lymph node larger than 1 cm in thorax CT, SUV above 2.5 in PET, and acceptance of metastasis at the Oncology Council was considered decisive. Diameter of the tumor, the shortest distance between the tumor and the mediastinum, the shortest distance between the tumor and the hilum, and the diameters of the largest mediastinal or hilar lymph nodes were measured from the thoracic computed tomography (CT) taken at the time of the diagnosis. The relationship between these values and lymph node metastasis was statistically evaluated.
Upon consideration of thoracic CT measurements, lymph node metastasis was found to have a statistically significant relationship with tumors with a large diameter (>55 mm) (p<0.001), tumors close to the mediastinum (<7 mm) (p=0.003), and tumors close to the hilum (<60 mm) (p=0.045). The evaluation of the distinctiveness of markers in diagnosis through ROC analysis showed AUC of 0.70 (p<0.001) for the largest tumor diameter, and the risk of lymph node metastasis was higher for lesions above 55 mm.
In thorax CT, Large tumor size, tumor close to mediastinum, tumor close to hilum, large lymph node, and high SUV value of lymph node in PET-CT are associated with increased chances of metastasis.
确定非小细胞肺癌肿块的大小和位置与淋巴结转移之间是否存在关联。
观察性研究。
于2013年11月至2018年11月在恰纳卡莱奥塞克兹马尔特大学医学肿瘤学系进行。
对112例接受非小细胞肺癌随访患者的记录进行回顾性分析。排除有远处器官转移(M1)和远处淋巴结转移(N3)、既往有恶性肿瘤病史、同步或异时性肿瘤以及无法获得所需数据的患者。对接受侵入性操作患者的淋巴结根据病理报告进行评估。对于未接受侵入性操作的患者,胸部CT中大于1 cm的淋巴结、PET中SUV高于2.5以及肿瘤学委员会判定为转移的情况被视为决定性因素。从诊断时所做的胸部计算机断层扫描(CT)测量肿瘤直径、肿瘤与纵隔之间的最短距离、肿瘤与肺门之间的最短距离以及最大纵隔或肺门淋巴结的直径。对这些值与淋巴结转移之间的关系进行统计学评估。
考虑胸部CT测量结果时,发现淋巴结转移与直径较大(>55 mm)的肿瘤(p<0.001)、靠近纵隔(<7 mm)的肿瘤(p=0.003)以及靠近肺门(<60 mm)的肿瘤(p=0.045)存在统计学显著关联。通过ROC分析对诊断中标志物的特异性进行评估,结果显示最大肿瘤直径的AUC为0.70(p<0.001),直径大于55 mm的病变发生淋巴结转移的风险更高。
在胸部CT中,肿瘤体积大、靠近纵隔、靠近肺门、淋巴结大以及PET-CT中淋巴结SUV值高与转移几率增加相关。